ジェダイトメディスン

Jadeite Medicines Inc. was established for Japanese patients with its mission of developing and commercializing novel innovative medicines developed globally.

Jadeite Medicines Inc. aims to become the best partner for innovative companies around the world and to meet the unmet medical needs in Japan.

Japan MHLW approves Bylvay® (odevixibat) for patients living with pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)
(Details here)